Marker Therapeutics, Inc. (MRKR)
USD 4.03
(-17.08%)
USD 4.03
(-17.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.31 Million | 9 Million | 1.24 Million | 466.78 Thousand | 213.19 Thousand | 205.99 Thousand |
| Cost of Revenue | 10.41 Million | 3.68 Million | 3.16 Million | 18.88 Million | 12.76 Million | 123.99 Million |
| Gross Profit | -7.1 Million | 5.32 Million | -1.92 Million | -18.41 Million | -12.55 Million | -123.79 Million |
| Operating Expenses | 17.89 Million | 38.95 Million | 40.71 Million | 29.35 Million | 22.74 Million | 148.37 Million |
| Selling, General and Administrative Expenses | 7.47 Million | 12.82 Million | 12.92 Million | 10.47 Million | 9.97 Million | 24.37 Million |
| Research and Development Expenses | 10.41 Million | 26.13 Million | 27.79 Million | 18.88 Million | 12.76 Million | 123.99 Million |
| Other Expenses | - | -232.97 Thousand | -2.4 Million | - | - | 116.04 Million |
| Cost and Expenses | 17.89 Million | 38.95 Million | 40.71 Million | 29.35 Million | 22.74 Million | 148.37 Million |
| Operating Income | -14.58 Million | -29.94 Million | -39.47 Million | -28.88 Million | -22.52 Million | -148.17 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3675.00 | -15.08 Thousand | -5700.00 | -179.74 Thousand | -1.1 Million | -213.72 Thousand |
| Earnings before Tax | -14.04 Million | -29.93 Million | -41.87 Million | -28.7 Million | -21.42 Million | -147.95 Million |
| Net Income | -14.04 Million | -29.91 Million | -41.87 Million | -28.52 Million | -20.32 Million | -147.95 Million |
| Earnings Per Share Basic | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.50 |
| Earnings Per Share Diluted | -1.93 | -3.58 | -5.47 | -6.06 | -4.46 | -77.50 |
| Weighted Average Shares Outstanding | 8.8 Million | 8.35 Million | 7.65 Million | 4.7 Million | 4.55 Million | 1.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.8 Million | 8.35 Million | 7.65 Million | 4.7 Million | 4.55 Million | 1.9 Million |
| Gross Margin | -2.15 | 0.59 | -1.55 | -39.45 | -58.87 | -600.95 |
| EBIT Margin | -3.56 | -2.92 | -29.25 | -59.64 | -104.41 | -719.11 |
| Profit Margin | -4.24 | -3.32 | -33.72 | -61.11 | -95.35 | -718.26 |
| EBITDA | -11.79 Million | -19.79 Million | -36.31 Million | -27.63 Million | -22.02 Million | -147.96 Million |
| Earnings Before Tax Margin | -4.40 | -3.33 | -31.79 | -61.88 | -105.67 | -719.30 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.16 Million | 1.24 Million | 1.05 Million | 3.31 Million | 257.6 Thousand | 762.65 Thousand |
| Cost of Revenue | - | 2.57 Million | 2.61 Million | 10.41 Million | 2.04 Million | 2.37 Million |
| Gross Profit | 1.16 Million | -1.33 Million | -1.56 Million | -7.1 Million | -1.78 Million | -1.61 Million |
| Operating Expenses | 3.47 Million | 3.79 Million | 3.99 Million | 17.89 Million | 3.2 Million | 4.13 Million |
| Selling, General and Administrative Expenses | 1.14 Million | 1.21 Million | 1.37 Million | - | 1.41 Million | 2.51 Million |
| Research and Development Expenses | 2.33 Million | 2.57 Million | 2.61 Million | - | 2.04 Million | 2.37 Million |
| Other Expenses | -1.16 Million | - | 1.23 Million | - | - | - |
| Cost and Expenses | 3.47 Million | 3.79 Million | 3.99 Million | 17.89 Million | 3.2 Million | 4.13 Million |
| Operating Income | -2.3 Million | -2.54 Million | -2.93 Million | -14.58 Million | -3.2 Million | -4.13 Million |
| Interest Expense | - | - | 84 Thousand | - | - | - |
| Income Tax Expense | - | -2.54 Million | 3675.00 | 3675.00 | -697.27 Thousand | -4.69 Million |
| Earnings before Tax | -2.19 Million | -2.39 Million | -2.73 Million | -14.04 Million | -2.98 Million | -4.09 Million |
| Net Income | -2.19 Million | -2.39 Million | -2.74 Million | -16.96 Million | -2.98 Million | 2.51 Million |
| Earnings Per Share Basic | -0.25 | -0.27 | -0.31 | - | -0.34 | -0.71 |
| Earnings Per Share Diluted | -0.25 | -0.27 | -0.31 | - | -0.34 | -0.71 |
| Weighted Average Shares Outstanding | 8.91 Million | 8.9 Million | 8.9 Million | 8.8 Million | 8.82 Million | 8.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.91 Million | 8.9 Million | 8.9 Million | 8.8 Million | 8.82 Million | 8.79 Million |
| Gross Margin | 1.00 | -1.07 | -1.48 | -2.15 | -6.94 | -2.12 |
| EBIT Margin | -1.97 | -2.05 | -2.78 | - | -12.42 | -5.42 |
| Profit Margin | -1.88 | -1.92 | -2.59 | -5.12 | -11.58 | 3.30 |
| EBITDA | -2.3 Million | -2.54 Million | -2.93 Million | - | -3.2 Million | -4.13 Million |
| Earnings Before Tax Margin | -1.97 | -2.05 | -2.78 | -4.40 | -12.42 | -5.42 |
5250
EGFEY
7181
6556
MODEL-B
MSAI